Cheryl Xu - 03 Jun 2025 Form 4 Insider Report for 60 DEGREES PHARMACEUTICALS, INC. (SXTP)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
05 Jun 2025, 20:53:09 UTC
Prior SEC filing
18 Dec 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Cheryl Xu

Key filing fact

Cheryl Xu filed Form 4 for 60 DEGREES PHARMACEUTICALS, INC. (SXTP) on 05 Jun 2025.

Key facts

  • This page summarizes Cheryl Xu's Form 4 filing for 60 DEGREES PHARMACEUTICALS, INC. (SXTP).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 05 Jun 2025, 20:53.

Change

  • Previous filing in this sequence was filed on 18 Dec 2024.
  • Current net transaction value: +$14,410.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001976957 Primary reporting owner

XU CHERYL

Relationship
Director
Address
C/O 60 DEGREES PHARMACEUTICALS, INC., 1025 CONNECTICUT AVENUE NW SUITE 1000, WASHINGTON
Signature
/s/ Cheryl Xu
Signature date
05 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SXTP transaction

Common Stock

Purchase

Transaction value
$8,610
Shares
+3,000
Change %
+28%
Price
$2.87
Shares after
13,816
Date
03 Jun 2025
Ownership
Direct
Footnotes
F1
SXTP transaction

Common Stock

Purchase

Transaction value
$5,800
Shares
+2,000
Change %
+14%
Price
$2.90
Shares after
15,816
Date
03 Jun 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects a 1-for-5 reverse stock split effective February 24, 2025, resulting in the reporting person's beneficial ownership being adjusted from 54,078 shares to 10,816 shares. Fractional shares were rounded up to the nearest whole share

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .